Black patients and other minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.
Category: Kaiser Health News
Patients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs
To drive down costs, insurers are bypassing hospital system pharmacies and delivering high-priced infusion drugs, including some used in chemotherapy, via third-party pharmacies. Smarting from losing out on billing for those drugs, hospitals and clinics are trying to convince states to limit this practice, known as “white bagging.”
A New Law Is Supposed to Protect Pregnant Workers — But What If We Don’t Know How?
During pregnancy, workers often face hazardous circumstances, including breathing toxic chemicals. On June 27, the Pregnant Workers Fairness Act began requiring employers to provide “reasonable accommodations.” But the new law has a big hole: Not nearly enough is known about which chemical exposures are dangerous for pregnant workers.
As Low-Nicotine Cigarettes Hit the Market, Anti-Smoking Groups Press for Wider Standard
The first FDA-authorized cigarettes with 95% less nicotine than traditional smokes will go on sale in California, Florida, and Texas starting in early July. Anti-smoking groups oppose greenlighting just one plant biotech’s products and instead urge federal regulators to set a low-nicotine standard for the entire industry.